KIT and leukemia: Additionally, there was not a significant change in the percentage of early hematopoietic cells (CD34+Linlow or CD34+Linlowc-Kit+) in the bone marrows of leukemia-bearing mice with both Ro 08-2750 doses (Fig. 6I).